Open original FDA record ↗Recall record
- FDA identifier
- Z-0285-2019
- Company in FDA record
- Magellan Diagnostics, Inc.
- FDA record creation date
- Oct 26, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Defect with the calibration button for lot 1808M. Level 1 and Level 2 Quality Control (QC) values will generate results of HIGH (>65 g/dL). Results for patient testing with this lot will be displayed as HIGH.
Source facts
- Action
- The firm, Magellan, notified the Customers (end users) by telephone or email on August 8, 2018 to provide notification of the deficiency of the LeadCare II Blood Lead Test Kit having Lot Number 1808M. Replacement Buttons and an "URGENT MEDICAL DEVICE CORRECTION" letter dated August 9 2018 ( were shipped on August 9, 2018, for delivery on Friday, August 10, 2018.) The letter described the product, problem and actions to be taken. The customers were instructed to do the following: 1. Do NOT use the Yellow calibration button marked 1808M. 2. Discard the Yellow calibration button that came with the LeadCare II Test Kit Lot 1808M. 3. Place the new Blue calibration button with the test kit and use for controls and patient testing with Lot 1808M. 4. Inform your staff of the calibration button exchange. 5. Complete the fax form record included with this letter and fax to 978-600-1480 or email a scanned copy of the completed form to reply@magellandx.com. If you have questions, please contact us at 800-275-0102 or LeadCareSupport@magellandx.com.
- Initiated
- 2018-08-08
- Root cause
- Process control
- Terminated
- 2020-05-12
- Distribution
- Worldwide distribution: US (Nationwide) and countries of: Spain and South Africa.
- Recall number
- Z-0285-2019
- Recall status
- Terminated
- CDRH record ID
- 167389
- FDA record created
- 2018-10-26
- Recall event number
- 81074